Patricia Ann Duffy

Array ( [id] => 3981613 [patent_doc_number] => 05861257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications' [patent_app_type] => 1 [patent_app_number] => 8/389011 [patent_app_country] => US [patent_app_date] => 1995-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11677 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861257.pdf [firstpage_image] =>[orig_patent_app_number] => 389011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739493 [patent_doc_number] => 05786180 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Monoclonal antibody 369.2B specific for .beta. A4 peptide' [patent_app_type] => 1 [patent_app_number] => 8/388463 [patent_app_country] => US [patent_app_date] => 1995-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 8691 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786180.pdf [firstpage_image] =>[orig_patent_app_number] => 388463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221797 [patent_doc_number] => 06010913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Isolated human tau peptide' [patent_app_type] => 1 [patent_app_number] => 8/403917 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 12776 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010913.pdf [firstpage_image] =>[orig_patent_app_number] => 403917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759045 [patent_doc_number] => 05843779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies' [patent_app_type] => 1 [patent_app_number] => 8/244951 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11202 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843779.pdf [firstpage_image] =>[orig_patent_app_number] => 244951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4007586 [patent_doc_number] => 05879677 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Method for inhibition of cerebral tissue factor mediated reperfusion damage' [patent_app_type] => 1 [patent_app_number] => 8/372887 [patent_app_country] => US [patent_app_date] => 1995-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 13079 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879677.pdf [firstpage_image] =>[orig_patent_app_number] => 372887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3600565 [patent_doc_number] => 05578451 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Methods and systems for screening potential alzheimer\'s disease therapeutics' [patent_app_type] => 1 [patent_app_number] => 8/371930 [patent_app_country] => US [patent_app_date] => 1995-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 9297 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578451.pdf [firstpage_image] =>[orig_patent_app_number] => 371930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770163 [patent_doc_number] => 05807671 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Method of screening for genetic predisposition to anticholinesterase therapy' [patent_app_type] => 1 [patent_app_number] => 8/370204 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 37 [patent_no_of_words] => 23220 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807671.pdf [firstpage_image] =>[orig_patent_app_number] => 370204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619594 [patent_doc_number] => 05641638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/367769 [patent_app_country] => US [patent_app_date] => 1995-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4680 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641638.pdf [firstpage_image] =>[orig_patent_app_number] => 367769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3495732 [patent_doc_number] => 05532172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Process and reagent for the determination of low density lipoproteins (LDL)' [patent_app_type] => 1 [patent_app_number] => 8/364702 [patent_app_country] => US [patent_app_date] => 1994-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2563 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532172.pdf [firstpage_image] =>[orig_patent_app_number] => 364702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528480 [patent_doc_number] => 05582998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Monoclonal antibodies against human TNF-binding protein I (TNF-BP I) and immunoassays therefor' [patent_app_type] => 1 [patent_app_number] => 8/365161 [patent_app_country] => US [patent_app_date] => 1994-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 9628 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/582/05582998.pdf [firstpage_image] =>[orig_patent_app_number] => 365161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807642 [patent_doc_number] => 05811310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'The Alz-50 monoclonal antibody and diagnostic assay for alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/362783 [patent_app_country] => US [patent_app_date] => 1994-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 17011 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811310.pdf [firstpage_image] =>[orig_patent_app_number] => 362783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235204 [patent_doc_number] => 06075010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Small molecular weight ligand-hexose containing clearing agents' [patent_app_type] => 1 [patent_app_number] => 8/350551 [patent_app_country] => US [patent_app_date] => 1994-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 31 [patent_no_of_words] => 49055 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075010.pdf [firstpage_image] =>[orig_patent_app_number] => 350551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827151 [patent_doc_number] => 05731410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Peptide for blocking autoantibody-evoked activation of glutamate receptor type 3 (GLUR3)' [patent_app_type] => 1 [patent_app_number] => 8/345527 [patent_app_country] => US [patent_app_date] => 1994-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 11093 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731410.pdf [firstpage_image] =>[orig_patent_app_number] => 345527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353178 [patent_doc_number] => 06200768 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Method of screening for compounds that dissolve paired helical filaments' [patent_app_type] => 1 [patent_app_number] => 8/244603 [patent_app_country] => US [patent_app_date] => 1994-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 138 [patent_no_of_words] => 25194 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200768.pdf [firstpage_image] =>[orig_patent_app_number] => 244603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739283 [patent_doc_number] => 05786163 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'BNP antibody and immunoassay using it' [patent_app_type] => 1 [patent_app_number] => 8/338558 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2739 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786163.pdf [firstpage_image] =>[orig_patent_app_number] => 338558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4153983 [patent_doc_number] => 06114133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Methods for aiding in the diagnosis of Alzheimer\'s disease by measuring amyloid-.beta. peptide (x-.gtoreq.41)' [patent_app_type] => 1 [patent_app_number] => 8/339141 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9040 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114133.pdf [firstpage_image] =>[orig_patent_app_number] => 339141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692185 [patent_doc_number] => 05679537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Immunoassays for measuring the avidity of rheumatoid factor in rheumatoid arthritis' [patent_app_type] => 1 [patent_app_number] => 8/329266 [patent_app_country] => US [patent_app_date] => 1994-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4095 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 258 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679537.pdf [firstpage_image] =>[orig_patent_app_number] => 329266 [rel_patent_id] =>[rel_patent_doc_number] =>)